Metro (B4B) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
29 Jul, 2025Executive summary
Sales in local currency grew 5.9% year-over-year to €24.0 billion for 9M 2024/25, with all segments and channels contributing.
Q3 2024/25 sales in local currency rose 7.4% year-over-year, with reported sales up 4.8% to €8.4 billion, impacted by negative FX effects, especially in Turkey.
Adjusted EBITDA for 9M 2024/25 was €803 million, slightly below prior year, mainly due to transformation costs in Germany.
Profit for the period attributable to shareholders was -€122 million for 9M 2024/25, compared to -€48 million in the prior year.
Financial highlights
9M 2024/25 reported sales: €23,988 million (+4.3% year-over-year); Q3: €8,357 million (+4.8%).
9M adjusted EBITDA: €803 million (prior year: €819 million); Q3 adjusted EBITDA: €336 million (prior year: €335 million).
EBIT for 9M: €177 million (prior year: €211 million); Q3: €78 million (prior year: €118 million).
Free cash flow for 9M: -€587 million (prior year: -€404 million).
Earnings per share for 9M: -€0.34 (prior year: -€0.13).
Outlook and guidance
Management expects total sales growth of 3% to 7% (currency- and portfolio-adjusted) for FY 2024/25.
Adjusted EBITDA is expected to increase slightly versus prior year, with transformation costs up to €150 million.
Germany and West segments expected to grow below guidance range; East and Other segments to exceed it.
Russia segment sales growth expected within guidance range, but volatility remains.
Latest events from Metro
- Sales and EBITDA rose, with delivery driving growth and positive outlook for FY 2025/26.B4B
Q1 202611 Feb 2026 - Q3 sales up 4%, EBITDA stable, FSD and digital strong; dividend payout unlikely.B4B
Q3 20241 Feb 2026 - Sales up 6%, but profitability declined; 2024/25 guidance and 2030 targets reaffirmed.B4B
Q4 202411 Jan 2026 - 6% revenue growth and higher EBITDA, with delivery as key driver; outlook remains positive.B4B
Q4 20254 Dec 2025 - Sales growth offset by cost inflation and delisting agreement with EPGC.B4B
Q2 20255 Jun 2025 - Sales up 7.1% in local currency, but net income and free cash flow declined year-over-year.B4B
Q1 20255 Jun 2025